Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News MyMD Pharmaceuticals Inc. MYMD

MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:MYMD)

Fundamentals Snapshot (NDAQ:MYMD)

Current News (NDAQ:MYMD)

Data Showing MyMD Pharmaceuticals' MYMD-1® May Extend Life and Improve Health Published in the Journal of Gerontology: Biological Sciences

Business Wire 8 days ago

MyMD Pharmaceuticals® Advances Phase 2 Multi-Center Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan

Business Wire July 26, 2022

MyMD Pharmaceuticals to Collaborate with Bascom Palmer Eye Institute to Study MYMD-1 in Ophthalmic Conditions

Business Wire July 12, 2022

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating MyMD Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

PR Newswire July 7, 2022

MyMD Pharmaceuticals Advances Phase 2 Multi-Center Clinical Trial of MYMD-1 as a Therapy for Delaying Aging and Extending Healthy Lifespan

Business Wire June 21, 2022

MyMD Pharmaceuticals Accelerates Pace of New Patient Dosing in Phase 2 Clinical Trial of MYMD-1 as a Therapy for Delaying Aging and Extending Healthy Lifespan

Business Wire April 5, 2022

MyMD Pharmaceuticals Announces Live Appearance on Cheddar News Network Today March 24

Business Wire March 24, 2022

MyMD Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial of MYMD-1 as a Therapy for Delaying Aging and Extending Healthy Lifespan

Business Wire February 23, 2022

MyMD Pharmaceuticals Announces Positive Clinical Data in Advance of Upcoming Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan

Business Wire February 8, 2022

Opinion & Analysis (NDAQ:MYMD)

No current opinion is available.

Bullboard Posts (NDAQ:MYMD)

RE:MYMD .... In PB Mode.... again !

Worth a repeat !!!!!!!!!
Iseneschal - August 5, 2021

MYMD .... In PB Mode.... again !

after a nice rally
Iseneschal - August 5, 2021

RE:MYMD ...mini pop

 LoL....bigger mini pop  Sweet
Iseneschal - August 5, 2021

MYMD ...mini pop

over $5 again
Iseneschal - August 5, 2021

MYMD ..... vols aren't good enough

staying clear from this....JMHO Might buy a dip though
Iseneschal - August 5, 2021

MYMD .... In PB Mode.... again !

Just sayin Careful this time.....NR's that released after the opening bell seldom work out.  Just my observation.  Cheers...
Iseneschal - August 5, 2021